Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04958239
Title A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim

pancreatic adenocarcinoma

skin melanoma

colorectal cancer

bladder urothelial carcinoma

stomach cancer

esophagus squamous cell carcinoma

lung non-small cell carcinoma

esophagus adenocarcinoma

malignant pleural mesothelioma

oral squamous cell carcinoma

cervical squamous cell carcinoma

ovarian carcinoma


BI 754091 + BI 765179

BI 765179

Age Groups: adult | senior
Covered Countries USA | ESP | BEL

Facility Status City State Zip Country Details
NEXT Oncology Recruiting San Antonio Texas 78229 United States Details
Brussels - UNIV Saint-Luc Recruiting Bruxelles 1200 Belgium Details
National Cancer Center Hospital East Recruiting Chiba, Kashiwa 277-8577 Japan Details
Hospital Vall d'Hebron Recruiting Barcelona 08035 Spain Details
Clínica Universidad de Navarra Recruiting Pamplona 31008 Spain Details
*Shaded cells indicate that there was no data available from for the field